These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26401075)

  • 1. Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis.
    Wang YC; Kong WZ; Jin QM; Chen J; Dong L
    World J Gastroenterol; 2015 Sep; 21(35):10104-12. PubMed ID: 26401075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of salvianolic acid B on NASH rat liver through restoring intestinal mucosal barrier function.
    Wang YC; Jin QM; Kong WZ; Chen J
    Int J Clin Exp Pathol; 2015; 8(5):5203-9. PubMed ID: 26191218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of SIRT3/FOXO1 Signaling Pathway in Rats with Non-alcoholic Steatohepatitis by Salvianolic Acid B.
    Wang Y; Chen J; Kong W; Zhu R; Liang K; Kan Q; Lou Y; Liu X
    Arch Med Res; 2017 Aug; 48(6):506-512. PubMed ID: 29224910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
    Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
    Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
    Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
    Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of catgut embedding at back-
    Zhou XL; Tang N; Wu T; Zhang Y; Chen Q; Wei WH; Zhou YN; Zhang DX; Qin FC; Yang W
    Zhongguo Zhen Jiu; 2020 Jan; 40(1):59-66. PubMed ID: 31930901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
    Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
    World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
    Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
    Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
    Yang ZR; Wang HF; Zuo TC; Guan LL; Dai N
    BMC Pharmacol Toxicol; 2016 Apr; 17():16. PubMed ID: 27075663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of soothing liver and invigorating spleen recipes on NF-kappaB signal pathway related genes and proteins in primary hepatocytes of rats with NASH].
    Yang QH; Xu YJ; Feng GF; Yang XS; Han L; Zhang YP; Wang H
    Zhong Yao Cai; 2013 Sep; 36(9):1469-76. PubMed ID: 24620695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
    Tan DY; Shi HY; Li CP; Zhong XL; Kang M
    World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise mitigates mitochondrial permeability transition pore and quality control mechanisms alterations in nonalcoholic steatohepatitis.
    Gonçalves IO; Passos E; Diogo CV; Rocha-Rodrigues S; Santos-Alves E; Oliveira PJ; Ascensão A; Magalhães J
    Appl Physiol Nutr Metab; 2016 Mar; 41(3):298-306. PubMed ID: 26905378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways.
    Wei Z; Xue Y; Xue Y; Cheng J; Lv G; Chu L; Ma Z; Guan S
    J Pharmacol Sci; 2021 Sep; 147(1):72-80. PubMed ID: 34294375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
    J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein profiling and functional analysis of liver mitochondria from rats with nonalcoholic steatohepatitis.
    You Y; Zhang Y; Lu Y; Hu K; Qu X; Liu Y; Lu B; Jin L
    Mol Med Rep; 2017 Sep; 16(3):2379-2388. PubMed ID: 28677739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation.
    Cahova M; Palenickova E; Dankova H; Sticova E; Burian M; Drahota Z; Cervinkova Z; Kucera O; Gladkova C; Stopka P; Krizova J; Papackova Z; Oliyarnyk O; Kazdova L
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G100-11. PubMed ID: 26045616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
    Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
    Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cigu Xiaozhi pills's influence on lipid peroxidation and TNF-alpha expression in liver tissues of rats with nonalcoholic steatohepatitis].
    Ma Y; Zhao J; Yang S; Jia Y
    Zhongguo Zhong Yao Za Zhi; 2010 May; 35(10):1292-7. PubMed ID: 20707200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.